Ron Scott

RON SCOTT is Chief Financial Officer of Basilea Pharmaceutica. Mr. Scott
obtained undergraduate and graduate degrees from Utah State University
and Harvard University in planning with an emphasis in finance. Mr.
Scott worked for the past eight years at F. Hoffmann-La Roche Ltd in
management positions in Pharmaceutical Finance, Licensing and the Roche
Corporate Finance Mergers and Acquisitions Group. His assignments
included managing the call, primary and secondary offerings of
Genentech, Roche’s biotech investment portfolio, acquisitions and
divestitures. Prior to joining F. Hoffmann-La Roche Ltd, Mr. Scott
worked for the Prudential Investment Corporation in the US as Director
in Prudential’s Finance and International Business Development Units,
managing divestitures and joint venture transactions.